Danielle Boyle: ITP Australia and New Zealand Patient Conference to Connect Patients, Families, and Experts
Danielle Boyle, Founder and CEO of ITP Australia and New Zealand, reposted from ITP Australia and New Zealand on LinkedIn:
”The annual ITP Australia and New Zealand Patient Conference is the anchor of our calendar, and it’s hard to believe we’re now less than a month away.
This year, we’ll gather at Melbourne Town Hall on Saturday, 7 March 2026, joined by an exceptional group of medical and scientific leaders who are deeply committed to advancing care and understanding for people living with Immune Thrombocytopenia.
What stays with me every year is the collective Exhale from patients and families as they realise they’re surrounded by people who genuinely understand their journey.
It’s a moment of recognition, relief, and connection — a reminder that no one has to navigate ITP alone.
We warmly welcome our industry partners, healthcare professionals, researchers, and anyone with an interest in ITP to join us.
It’s an opportunity to hear directly from the community, understand the questions that matter most to patients, and experience the impact of bringing lived experience and clinical expertise together.
Grab your tickets today.”
Quoting ITP Australia and New Zealand‘s post:
”One month until the ITPANZ Annual Patient Conference in Melbourne.
This event brings together patients, families, clinicians, and researchers for a day of education, discussion, and shared insight into Immune Thrombocytopenia.
The program includes expert presentations, treatment updates, and lived‑experience perspectives designed to support informed, patient‑centred care.
Stay updated with Hemostasis Today.
-
Apr 2, 2026, 04:47Augustina Isioma Ikusemoro: A Small Antigen with Big Clinical Consequences
-
Apr 2, 2026, 04:28Mohammed Almohammadi: Etiologic Spectrum and Diagnostic Challenges of Hypocellular Marrow Findings
-
Apr 2, 2026, 04:18Emmanuele Kouvousis: Physical Inactivity as a Leading Global Health Risk
-
Apr 2, 2026, 04:03Robert Lufkin: The Misleading Concept of Metabolically Healthy Obesity in Childhood
-
Apr 1, 2026, 23:00Wolfgang Miesbach: What Goes Wrong When Approved Gene Therapies Get Withdrawn?
-
Apr 1, 2026, 22:00Aurelio Maggio: Congratulations to Mariasanta Napolitano on Her 1st Year Leading the Haematology and Rare Disease Uni tat ”V. Cervello” Hospital
-
Apr 1, 2026, 21:21Shubham Misra: CCL2 As a Potential Biomaker for Post-Stroke Seizures, Epileptiform Discharges and Mortality
-
Apr 1, 2026, 21:00Johns Hopkins All Children’s Hospital Becomes The 1st U.S Pediatric VTE Center of Excellence – NBCA
-
Apr 1, 2026, 20:17Aswin K Mohan: The Most Common Misconceptions on Blood Donation